[Thalidomide treatment of patients with refractory myeloma in the institutes participating in the Japan Myeloma Study Group].

Murakami, Hirokazu; Handa, Hiroshi; Imai, Kohzoh; Kanakura, Yuzuru; Kosaka, Masaaki; Sawamura, Morio; Shimazaki, Chihiro; Suzuki, Kenshi; Ishii, Akihiro; Takagi, Toshiyuki; Taniwaki, Masashi; Togawa, Atsushi; Hata, Hiroyuki; Wakayama, Toshio; Takatsuki, Kiyoshi

Murakami, Hirokazu; Handa, Hiroshi; Imai, Kohzoh; Kanakura, Yuzuru; Kosaka, Masaaki; Sawamura, Morio; Shimazaki, Chihiro; Suzuki, Kenshi; Ishii, Akihiro; Takagi, Toshiyuki; Taniwaki, Masashi; Togawa, Atsushi; Hata, Hiroyuki; Wakayama, Toshio; Takatsuki, Kiyoshi.

Affiliation

Murakami H; School of Health Sciences, Faculty of Medicine, Gunma University.

Rinsho Ketsueki ; 45(6): 468-72, 2004 Jun.

Article de Ja | MEDLINE | ID: mdl-15287523

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thalidomide / Myélome multiple Type d'étude: Clinical_trials Limites: Female / Humans / Male / Middle aged Langue: Ja Journal: Rinsho Ketsueki Année: 2004 Type de document: Article Pays de publication: Japon

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links